Avectas
Ann Brady, PhD., currently serves as President, Theravance Biopharma Ireland and a board member of An2H Discovery Ltd. Ann brings over 20 years experience in the bio-pharma industry through global roles in business development, alliance management, corporate strategy and commercial operations gained in both developed and emerging markets. Ann served in senior executive roles at Shire, plc and élan Corporation, plc. She holds a BA (Mod) Natural Sciences and a PhD (Chemistry) from Trinity College, Dublin and is a member of the Institute of Directors of Ireland (MIoD).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Avectas
1 followers
Avectas is a cell engineering business focused on improving the cost, manufacturing, and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene-modified cell therapy products, with partners.